Chimeric Therapeutics Ltd. is a clinical stage cell therapy company, which engages in the development and commercialization of cell therapies in oncology. Its products include NK Cell Derived Allogenic Therapies and T Cell Derived Autologous Therapies. The company was founded by Paul A. Hopper in 2020 and is headquartered in Carlton South, Australia.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Chimeric Therapeutics Limited?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Chimeric Therapeutics Limited market cap is $3.25M.
What is the 52-week high for Chimeric Therapeutics Limited?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Chimeric Therapeutics Limited 52 week high is $0.001 as of September 06, 2025.
What is the 52-week low for Chimeric Therapeutics Limited?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Chimeric Therapeutics Limited 52 week low is $0.001 as of September 06, 2025.
What is Chimeric Therapeutics Limited stock price today?
Chimeric Therapeutics Limited stock price today is $0.001.
What was Chimeric Therapeutics Limited stock price yesterday?
Chimeric Therapeutics Limited stock price yesterday was $0.03.
What is the PE ratio of Chimeric Therapeutics Limited?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Chimeric Therapeutics Limited’s P/E ratio is -0.24.
What is the Price-to-Book ratio of Chimeric Therapeutics Limited?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Chimeric Therapeutics Limited P/B ratio is 1.5625.
What is the 50-day moving average of Chimeric Therapeutics Limited?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Chimeric Therapeutics Limited 50-day moving average is $0.001.
